These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 12379363

  • 1. Evolution of catalytic antibody repertoire in autoimmune mice.
    Nishi Y.
    J Immunol Methods; 2002 Nov 01; 269(1-2):213-33. PubMed ID: 12379363
    [Abstract] [Full Text] [Related]

  • 2. Molecular evolution of catalytic antibodies in autoimmune mice.
    Sun J, Takahashi N, Kakinuma H, Nishi Y.
    J Immunol; 2001 Nov 15; 167(10):5775-85. PubMed ID: 11698451
    [Abstract] [Full Text] [Related]

  • 3. Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?
    Tawfik DS, Chap R, Green BS, Sela M, Eshhar Z.
    Proc Natl Acad Sci U S A; 1995 Mar 14; 92(6):2145-9. PubMed ID: 7892238
    [Abstract] [Full Text] [Related]

  • 4. Improved generation of catalytic antibodies by MRL/MPJ-lpr/lpr autoimmune mice.
    Takahashi N, Kakinuma H, Hamada K, Shimazaki K, Yamasaki Y, Matsushita H, Nishi Y.
    J Immunol Methods; 2000 Feb 21; 235(1-2):113-20. PubMed ID: 10675763
    [Abstract] [Full Text] [Related]

  • 5. Selective chemotherapeutic strategies using catalytic antibodies: a common pro-moiety for antibody-directed abzyme prodrug therapy.
    Kakinuma H, Fujii I, Nishi Y.
    J Immunol Methods; 2002 Nov 01; 269(1-2):269-81. PubMed ID: 12379367
    [Abstract] [Full Text] [Related]

  • 6. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
    Odenbaugh AL, Helms ED, Iverson BL.
    Bioorg Med Chem; 2000 Feb 01; 8(2):413-26. PubMed ID: 10722164
    [Abstract] [Full Text] [Related]

  • 7. Catalytic antibodies in autoimmune mice.
    Nishi Y, Takahashi N, Kakinuma H, Sun J.
    Chem Immunol; 2000 Feb 01; 77():58-79. PubMed ID: 11706706
    [No Abstract] [Full Text] [Related]

  • 8. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
    Charbonnier JB, Carpenter E, Gigant B, Golinelli-Pimpaneau B, Eshhar Z, Green BS, Knossow M.
    Proc Natl Acad Sci U S A; 1995 Dec 05; 92(25):11721-5. PubMed ID: 8524836
    [Abstract] [Full Text] [Related]

  • 9. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.
    Tawfik DS, Lindner AB, Chap R, Eshhar Z, Green BS.
    Eur J Biochem; 1997 Mar 01; 244(2):619-26. PubMed ID: 9119032
    [Abstract] [Full Text] [Related]

  • 10. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD, Schultz PG.
    J Mol Biol; 1998 Jan 09; 275(1):95-111. PubMed ID: 9451442
    [Abstract] [Full Text] [Related]

  • 11. Mechanistic analysis of the phosphonate transition-state analogue-derived catalytic and non-catalytic antibody.
    Nishi Y, Yamamoto N, Shimazaki K, Takahashi-Ando N, Kakinuma H, Jialin S, Ruzheinikov SN, Muranova TA, Rice DW, Kajihara Y.
    J Biochem; 2007 Oct 09; 142(4):421-33. PubMed ID: 17981825
    [Abstract] [Full Text] [Related]

  • 12. A comparative analysis of the immunological evolution of antibody 28B4.
    Yin J, Mundorff EC, Yang PL, Wendt KU, Hanway D, Stevens RC, Schultz PG.
    Biochemistry; 2001 Sep 11; 40(36):10764-73. PubMed ID: 11535051
    [Abstract] [Full Text] [Related]

  • 13. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice.
    Suh CH, Freed JH, Cohen PL.
    J Immunol; 2003 Feb 15; 170(4):2229-35. PubMed ID: 12574397
    [Abstract] [Full Text] [Related]

  • 14. Crystal structures of the free and liganded form of an esterolytic catalytic antibody.
    Wedemayer GJ, Wang LH, Patten PA, Schultz PG, Stevens RC.
    J Mol Biol; 1997 May 02; 268(2):390-400. PubMed ID: 9159478
    [Abstract] [Full Text] [Related]

  • 15. A common ancestry for multiple catalytic antibodies generated against a single transition-state analog.
    Miyashita H, Hara T, Tanimura R, Tanaka F, Kikuchi M, Fujii I.
    Proc Natl Acad Sci U S A; 1994 Jun 21; 91(13):6045-9. PubMed ID: 8016113
    [Abstract] [Full Text] [Related]

  • 16. Structure-function analysis and molecular modeling of DNase catalytic antibodies.
    Zein HS, Teixeira da Silva JA, Miyatake K.
    Immunol Lett; 2010 Mar 10; 129(1):13-22. PubMed ID: 20097230
    [Abstract] [Full Text] [Related]

  • 17. Amino acid sequences and hapten binding of catalytic and noncatalytic antibodies against N(alpha)-(5'-phosphopyridoxyl)-L-lysine.
    Mouratou B, Gramatikova S, Kunz B, Christen P.
    Mol Immunol; 2000 Aug 10; 37(11):633-40. PubMed ID: 11164891
    [Abstract] [Full Text] [Related]

  • 18. Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9.
    Mouratou B, Stetefeld J.
    Biochemistry; 2004 Jun 01; 43(21):6612-9. PubMed ID: 15157094
    [Abstract] [Full Text] [Related]

  • 19. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice.
    Bloom DD, Davignon JL, Cohen PL, Eisenberg RA, Clarke SH.
    J Immunol; 1993 Feb 15; 150(4):1579-90. PubMed ID: 8432994
    [Abstract] [Full Text] [Related]

  • 20. Structural convergence in the active sites of a family of catalytic antibodies.
    Charbonnier JB, Golinelli-Pimpaneau B, Gigant B, Tawfik DS, Chap R, Schindler DG, Kim SH, Green BS, Eshhar Z, Knossow M.
    Science; 1997 Feb 21; 275(5303):1140-2. PubMed ID: 9027317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.